Sophorolipids: Production, Characterization and Biologic Activity

2013 ◽  
pp. 377-417 ◽  
Keyword(s):  
2020 ◽  
Vol 15 ◽  
Author(s):  
Geeta Aggarwal ◽  
Manju Nagpal ◽  
Ameya Sharma ◽  
Vivek Puri ◽  
Gitika Arora Dhingra

Background: Biopharmaceuticals such as Biologic medicinal products have been in clinical use over the past three decades and have benefited towards the therapy of degenerative and critical metabolic diseases. It is forecasted that market of biologics will be going to increase at a rate of 20% per year, and by 2025, more than ˃ 50% of new drug approvals may be biological products. The increasing utilization of the biologics necessitates for cost control, especially for innovators products that have enjoyed a lengthy period of exclusive use. As the first wave of biopharmaceuticals is expired or set to expire, it has led to various opportunities for the expansion of bio-similars i.e. copied versions of original biologics with same biologic activity. Development of biosimilars is expected to promote market competition, meet worldwide demand, sustain the healthcare systems and maintain the incentives for innovation. Methods: Appraisal of published articles from peer reviewed journals, PubMed literature, latest news and guidelines from European Medicine Agency, US Food Drug Administration (FDA) and India are used to identify data for review. Results: Main insight into the quality requirements concerning biologics, current status of regulation of biosimilars and upcoming challenges lying ahead for the upgrading of marketing authorization of bio-similars has been incorporated. Compiled literature on therapeutic status, regulatory guidelines and the emerging trends and opportunities of biosimilars has been thoroughly stated. Conclusion: Updates on biosimilars will support to investigate the possible impact of bio-similars on healthcare market.


1987 ◽  
Vol 262 (30) ◽  
pp. 14663-14671 ◽  
Author(s):  
D A McClain ◽  
H Maegawa ◽  
J Lee ◽  
T J Dull ◽  
A Ulrich ◽  
...  

2006 ◽  
Vol 985 ◽  
Author(s):  
Brian D Marshall ◽  
Thomas A. Oliver ◽  
Zell E. Peterman

AbstractWater samples (referred to as puddle water samples) were collected from the surfaces of a conveyor belt and plastic sheeting in the unventilated portion of the Enhanced Characterization of the Repository Block (ECRB) Cross Drift in 2003 and 2005 at Yucca Mountain, Nevada. The chemistry of these puddle water samples is very different than that of pore water samples from borehole cores in the same region of the Cross Drift or than seepage water samples collected from the Exploratory Studies Facility tunnel in 2005. The origin of the puddle water is condensation on surfaces of introduced materials and its chemistry is dominated by components of the introduced materials. Large CO2 concentrations may be indicative of localized chemical conditions induced by biologic activity.


1985 ◽  
Vol 23 (1) ◽  
pp. 81-85 ◽  
Author(s):  
James M. Londowski ◽  
Larry K. Revelle ◽  
Susan Bollman Kost ◽  
Robert A. Corradino ◽  
Rajiv Kumar
Keyword(s):  

2009 ◽  
Vol 38 (2) ◽  
pp. 225-234 ◽  
Author(s):  
Stavros Thomopoulos ◽  
Rosalina Das ◽  
Shelly Sakiyama-Elbert ◽  
Matthew J. Silva ◽  
Nichole Charlton ◽  
...  

1977 ◽  
Vol 252 (21) ◽  
pp. 7434-7436 ◽  
Author(s):  
C.B. Srikant ◽  
D. Freeman ◽  
K. McCorkle ◽  
R.H. Unger

Sign in / Sign up

Export Citation Format

Share Document